Skip to main content
Premium Trial:

Request an Annual Quote

Preparing for the Onslaught

In October, the UK's National Health Service will launch a pilot program to train NHS scientists to help patients and doctors understand genetic tests, reports the UK's Times Online. The pilot program in the West Midlands will cost £4.5 million (about $7.4 million) and, once trained, the scientists will have the background to help primary care and hospital-based physicians on which genetic tests may be needed and interpretation of results. The scientists may also aid in doctor-patients conferrals. "We need scientists who are more clinically trained, so they can work with the changing and diffuse nature of genetics," says Sue Hill, the chief scientific officer Department of Health. "Genetic scientists may actually start to sit in clinics with medics and play a key role, explaining to patients what the results are showing. This isn't about scientists replacing medics, it's about working together in a team."

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.